Richard Finn

Dr. Richard Finn, a medical oncologist at UCLA with expertise in liver cancer clinical trials, and Dr. Julius Chapiro, an interventional radiologist at Yale, delve into groundbreaking treatments for hepatocellular carcinoma. They discuss the synergy between transarterial chemoembolization (TACE) and immunotherapy, revealing how recent studies shift treatment paradigms. The duo emphasizes the need for a multidisciplinary approach, highlights advancements in biopsy techniques, and the importance of robust data in guiding treatment decisions.